Rheumatoid Arthritis, Satisfaction
Conditions
Brief summary
A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.
Detailed description
In the last decade, China has made quick progress on treatment of rheumatoid arthritis. However, the improvement of remission rate cannot fully represent needs of patients for health. To meet health demands of patients and improve their satisfaction, an efficacy evaluation system based on the outcome report of patients should be established. A questionnaire for this research is designed and mended in view of TSQM-II treatment satisfaction questionnaire and the actual situation of RA diagnosis and treatment in China. An investigation on treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for this disease is carried out based on 120 rheumatoid immunologists and 1,200 rheumatoid arthritis patients (1:10) from Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research concludes rheumatoid specialist physicians for doctor population, and persons aged over 18 for patient population who has been confirmed as RA for 6 months above, excluding patients with Chinese reading comprehension barriers or without any RA treatment. Finally, summarize and analyze the total score of satisfaction from doctors and patients, average score of doctors and patients for various medical demands, as well as the satisfaction of patients about communication and service during medical treatment.
Interventions
OTHERTSQM-II
Treatment Satisfaction Questionnaire for Medication (TSQM Version II) will be used in all groups
Sponsors
Chinese SLE Treatment And Research Group
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
Doctors - registered rheumatoid specialist physicians subordinated to the 12 designated hospitals Patients - aged over 18, confirming RA for more than 6 months
Exclusion criteria
Doctors - N/A Patients - with Chinese reading comprehension barriers (unable to complete the questionnaire independently), without any RA treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total score of patient satisfaction | 1 day | Total score of patient satisfaction |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Average score of patients for long-term treatment demands | 1 day | Average score of patients for long-term treatment demands |
| Average score of patients for new drug demands | 1 day | Average score of patients for new drug demands |
| Total score of doctor satisfaction | 1 day | Total score of doctor satisfaction |
| Average score of patients for various treatment demands | 1 day | Average score of patients for various treatment demands |
| Average score of doctors for long-term treatment demands | 1 day | Average score of doctors for long-term treatment demands |
| Average score of doctors for new drug demands | 1 day | Average score of doctors for new drug demands |
| Average score of doctors for various treatment demands | 1 day | Average score of doctors for various treatment demands |
Countries
China
Outcome results
None listed